Media

- ITI-1000 targets CMV with Immunomic Therapeutics’ immunotherapy UNITE™ platform - ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. announced today that it has assumed sponsorship of the Investigational New Drug (IND)

ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that it has appointed brain tumor expert E. Antonio ‘Nino’ Chiocca, M.D., Ph.D., Harvey W.

Precision: Lung Cancer will bring together scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations. Discussions will revolve around translating the latest

United Scientific Group welcomes Fifth Edition of International Conference on Vaccines Research and Development (Vaccines R&D-2019) in Boston, MA during November 18-20, 2019. This meeting will cover broad range of

Presented by Maryland Life Sciences, a division of the Maryland Tech Council, the Bio Innovation Conference showcases Maryland’s innovation and successes in the life sciences industry. This conference provides a

JOIN SNO IN PHOENIX! The SNO annual meeting is the world’s largest neuro-oncology conference, attracting over 2400 researchers and clinician-scientists from more than 40 countries. Spanning all neuro-oncology disciplines, professions,

The premier international meeting featuring novel cancer therapeutics. Oct. 26-30, 2019 Hynes Convention Center Boston, Massachusetts Organizing Committee Cochairs Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore,

ABOUT THE ONCOLOGY 2019 Fearless commitment for a Cancer free world Hilaris Conferences warmly invite you to meet inspiring speakers and experts for the conference Oncology 2019 in Paris, France

The ESMO Congress is the appointment in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world to get together, learn about the latest

July 12, 2019 08:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the appointment of Andrew Eisen, M.D., Ph.D. as

June 20, 2019 20:05 UTC ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the promotion of Teri Heiland, Ph.D. to Chief Scientific Officer.

May 30, 2019 04:05 PM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the China